SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 267 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,281 | -64.4% | 119 | -61.2% | 0.00% | -100.0% |
| Q2 2023 | $9,229 | -5.3% | 307 | +14.1% | 0.00% | 0.0% |
| Q1 2023 | $9,746 | +61.7% | 269 | +59.2% | 0.00% | 0.0% |
| Q4 2022 | $6,028 | -66.5% | 169 | -68.8% | 0.00% | -50.0% |
| Q3 2022 | $18,000 | +350.0% | 542 | +281.7% | 0.00% | +100.0% |
| Q2 2022 | $4,000 | 0.0% | 142 | +10.1% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 129 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | 0.0% | 129 | -14.0% | 0.00% | -100.0% |
| Q3 2021 | $4,000 | 0.0% | 150 | +10.3% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | +33.3% | 136 | +5.4% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 129 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $3,000 | +50.0% | 129 | +19.4% | 0.00% | – |
| Q3 2020 | $2,000 | -33.3% | 108 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $3,000 | +50.0% | 108 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | +100.0% | 108 | +77.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 61 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -96.4% | 61 | -92.9% | 0.00% | -100.0% |
| Q2 2019 | $28,000 | +1300.0% | 858 | +1306.6% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 61 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $2,000 | -33.3% | 61 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $3,000 | -40.0% | 61 | -38.4% | 0.00% | -50.0% |
| Q2 2018 | $5,000 | +150.0% | 99 | +62.3% | 0.00% | +100.0% |
| Q1 2018 | $2,000 | -33.3% | 61 | -41.3% | 0.00% | 0.0% |
| Q4 2017 | $3,000 | 0.0% | 104 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $3,000 | – | 104 | +70.5% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 61 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 61 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $1,000 | 0.0% | 61 | -57.0% | 0.00% | 0.0% |
| Q4 2015 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $1,000 | – | 142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |